Revvity Past Earnings Performance

Past criteria checks 3/6

Revvity's earnings have been declining at an average annual rate of -10.9%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 2.7% per year. Revvity's return on equity is 3.3%, and it has net margins of 9.5%.

Key information

-10.9%

Earnings growth rate

-13.0%

EPS growth rate

Life Sciences Industry Growth36.9%
Revenue growth rate-2.7%
Return on equity3.3%
Net Margin9.5%
Last Earnings Update29 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Revvity makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0KHE Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
29 Sep 242,722258949199
30 Jun 242,708197942202
31 Mar 242,726183943211
31 Dec 232,751180942217
01 Oct 232,796213898222
02 Jul 232,837250903222
02 Apr 233,024353918221
01 Jan 233,312513940222
02 Oct 223,5995991,001222
03 Jul 223,748637989219
03 Apr 223,483694885195
02 Jan 223,828889854200
03 Oct 214,1551,086893197
04 Jul 214,2571,155893197
04 Apr 214,4381,074961217
03 Jan 212,663631729146
04 Oct 203,234412887196
05 Jul 202,977294866191
05 Apr 202,887226845190
29 Dec 192,884228833189
29 Sep 192,835235806194
30 Jun 192,802251794197
31 Mar 192,783247790196
30 Dec 182,778237809194
30 Sep 182,663128761180
01 Jul 182,543149719166
01 Apr 182,387147667152
31 Dec 172,257157615139
01 Oct 172,182258587135
02 Jul 172,142215580129
02 Apr 172,132210584128
01 Jan 172,116216585124
02 Oct 161,999198574108
03 Jul 162,048199583110
03 Apr 162,076190583110
03 Jan 162,105189586113
04 Oct 152,263176661127
28 Jun 152,241164657126
29 Mar 152,234167656124
28 Dec 142,070130648108
28 Sep 142,221203576123
29 Jun 142,201201577124
30 Mar 142,185176579128
29 Dec 132,158174581132

Quality Earnings: 0KHE has a large one-off loss of $105.6M impacting its last 12 months of financial results to 29th September, 2024.

Growing Profit Margin: 0KHE's current net profit margins (9.5%) are higher than last year (7.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0KHE's earnings have declined by 10.9% per year over the past 5 years.

Accelerating Growth: 0KHE's earnings growth over the past year (20.5%) exceeds its 5-year average (-10.9% per year).

Earnings vs Industry: 0KHE earnings growth over the past year (20.5%) exceeded the Life Sciences industry 5.4%.


Return on Equity

High ROE: 0KHE's Return on Equity (3.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies